• By ICR Secretariat
  • Posted Thursday, May 27, 2021

Off-the-shelf CAR-T, a Tagrisso rival and the next breast cancer drugs: a look ahead at ASCO

https://www.biopharmadive.com/news/asco-2021-abstracts-allogene-eqrx-serds/600509/

On Wednesday evening, cancer doctors and researchers got an early peek at the clinical trial results set to be presented next month at the American Society of Clinical Oncology’s annual meeting.